NAT10 is overexpressed in CRC tissue and ac4C modification of targeted genes mediated by NAT10 inhibits ferroptosis and activates Wnt/β‐catenin pathway to promote the progression of CRC. This evidence concerns the gene NAT10 and colorectal carcinoma.